Nicotinamide Adenine Dinucleotide as a Potential Biomarker for Graft Viability During Normothermic Machine Perfusion: An Ex Vivo Rodent Study
Artificial Organs · 2026
DOI: 10.1111/aor.70197 ↗Kurz gefasst
Fachartikel in der Zeitschrift Artificial Organs, 2026. Verfasst von Kilian A Walter und 12 weiteren Autor:innen. Beteiligte Einrichtung: Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Department of Surgery, Experim…. Hauptthemen laut MEDLINE: Perfusion, NAD, Liver Transplantation, Liver. Die Arbeit nennt 48 Literaturangaben.
Abstract (Originalsprache)
Background
The shortage of donor organs has increased the use of extended criteria donor (ECD) grafts in liver transplantation. Normothermic machine perfusion (NMP) could be used as a platform for real‐time quality assessment, which is crucial since ECD grafts are more susceptible to ischemia–reperfusion injury (IRI). As nicotinamide adenine dinucleotide (NAD + ) is a central mediator of cellular antioxidativedefense, reduced intracellular NAD (iNAD + ) levels in grafts sustaining greater injury may reflect diminished antioxidative capacity and could serve as a marker to assess graft quality. This study aimed to investigate iNAD + in comparison to existing damage‐associated parameters for liver graft quality in a small animal NMP model simulating ECD conditions through advanced donor age, prolonged cold ischemia time (CIT), and donation after circulatory death (DCD).
Methods
Fifty‐nine male Sprague–Dawley rat livers were analyzed across six experimental groups defined by donor age (3 months [young] or 12 months [elderly]), procurement modality (standard procurement or donation after circulatory death [DCD]), and cold ischemia time (CIT; 6 h or 12 h), followed by 6 h of NMP. No livers were excluded from analysis. iNAD + levels were quantified using a colorimetric enzymatic assay.
Results
Perfusate iNAD + levels continuously rose over time during NMP and differed significantly between intervention groups ( p = 0.003). iNAD+ correlated negatively with ALT levels (R = −0.36, p = 0.024) and liver tissue necrosis in grafts (perfusate R = −0.24, p = 0.17; tissue R = −0.19, p = 0.2), although these associations did not reach statistical significance. Long CIT, higher donor age, and DCD procurement were associated with lower iNAD+ levels. iNAD+ did not correlate with lactate clearance or bile production (both p > 0.05). A non‐significant trend toward a positive association between iNAD+ and glucose metabolism was observed ( R = 0.29, p = 0.077).
Discussion
Higher perfusate iNAD+ levels were associated with better organ performance, consistent with iNAD+ reflecting the graft's antioxidative metabolic capacity. Lower iNAD+ levels in elderly and DCD grafts aligned with established damage markers. Perfusate iNAD+ may therefore offer a complementary tool for evaluating metabolic activity and organ performance during NMP, pending prospective validation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Department of Surgery, Experimental Surgery, Campus Charité Mitte, Campus Virchow-Klinikum, Berlin,…
- DeepSpin GmbH, Berlin, Germany.
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, BIH Charité Clinician Scientist Program, Berlin, Germany.
- Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum Der Charité (DHZC), Berlin, Germany.
- Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany.
ORCID-Profile: Kilian A Walter, Leonard Boerger, Anna Pietsch, Phillip Brunnbauer, Can Kamali, Karl H Hillebrandt, Jasper Iske, Johann Pratschke, Igor M Sauer, Nathanael Raschzok, Simon Moosburner
Zitieren
APA
Walter, K. A., Boerger, L., Pietsch, A., Gilles, L., Brunnbauer, P., Kamali, C., Hillebrandt, K. H., Iske, J., Pratschke, J., Sauer, I. M., Raschzok, N., Krenzien, F., & Moosburner, S. (2026). Nicotinamide Adenine Dinucleotide as a Potential Biomarker for Graft Viability During Normothermic Machine Perfusion: An Ex Vivo Rodent Study. Artificial Organs. https://doi.org/10.1111/aor.70197
Vancouver
Walter KA, Boerger L, Pietsch A, Gilles L, Brunnbauer P, Kamali C, et al. Nicotinamide Adenine Dinucleotide as a Potential Biomarker for Graft Viability During Normothermic Machine Perfusion: An Ex Vivo Rodent Study. Artificial Organs. 2026. doi:10.1111/aor.70197
BibTeX
@article{Walter2026,
author = {Walter, Kilian A and Boerger, Leonard and Pietsch, Anna and Gilles, Linda and Brunnbauer, Phillip and Kamali, Can and Hillebrandt, Karl H and Iske, Jasper and Pratschke, Johann and Sauer, Igor M and Raschzok, Nathanael and Krenzien, Felix and Moosburner, Simon},
title = {Nicotinamide Adenine Dinucleotide as a Potential Biomarker for Graft Viability During Normothermic Machine Perfusion: An Ex Vivo Rodent Study},
journal = {Artificial Organs},
year = {2026},
doi = {10.1111/aor.70197}
}
EUVIMED